* Nutrient Reference Value
Hemp (Cannabis sativa) oil extract, VESIsorb® colloidal delivery system (medium chain triglycerides, antioxidant (tocophersolan), mono and diglycerides, fatty acids, natural flavoring). Softgel capsule (gelatin, glycerin, carob, water).
If you are pregnant or lactating, have any health condition or are taking any medication, consult your health professional before use. Use only if safety seal is intact. Food supplements should not be used as a substitute for a varied diet. Do not exceed the stated daily dosage. Keep out of the reach of young children.
CBD VESIsorb® is derived from hemp and extracted using solvent-free, clean CO2 technology, an environmentally friendly and efficient method. Featuring a broad-spectrum of over 10 phytocannabinoids, including 25 mg CBD per capsule, 10-12mg beta-caryophyllene (BCP), and other terpenes. Each batch is THC-free and tested to ensure non-detectable levels. The patented VESIsorb® lipid-based delivery system has been shown to increase bioavailability and enhance absorption of CBD.
As a food supplement, take 1 softgel capsule daily, with or between meals, or as directed by a healthcare professional.
Serving size 1 capsule
• Offers 25mg CBD per softgel
© 2022 Nutritional Ecological Environmental Delivery System
• Solvent-free, supercritical CO2 extracted
VESIsorb®, a registered trademark of SourceOne Global Partners, is a naturally self-assembling colloidal droplet delivery system that has been well-recognized as the industry leader for improving the bioavailability of poorly absorbed natural ingredients, like cannabinoids and terpenes. Since 2005, the superiority of this technology has consistently been demonstrated in well-designed pilot and peer-reviewed published pharmacokinetic absorption and bioavailability studies, as well as third-party meta-analyses.
Pure Encapsulations New VESIsorb® Formulated Hemp
• Enhanced-bioavailability VESIsorb® technology offers a unique, self-assembling colloidal system to enhance absorption by promoting the ability of the hemp extract to dissolve readily in an aqueous environment
The new Pure Encapsulations Hemp Extract is a patent protected cannabinoid formulation utilizing an innovative drug delivery system with measured bioavailability and proven stability data. This cannabidiol (CBD) soft gel formulations uses the patented VESIsorb® drug delivery system for dramatically improved absorption and bioavailability.
• Broad-spectrum hemp extract with 10+ phytocannabinoids, including CBD, beta-caryophyllene (BCP), and other terpenes
Hemp, also known as Cannabis sativa, is an annual herb of the family Cannabaceae with a long history of use. This extract is derived from 100% US-sourced, field-grown agricultural hemp and is extracted using solvent-free, clean CO2 technology, an environmentally friendly and efficient method. Each batch is THC-free and tested to ensure non-detectable levels even less than allowable limits.
Geocann (Fort Collins, CO) and Nestlé Health Science (Switzerland) launched broad-spectrum CBD soft-gel formulations with VESIsorb drug delivery system for improved absorption and bioavailability in the European market.
VESIsorb—a naturally self-assembling colloidal droplet delivery system that improves the bioavailability of poorly absorbed natural ingredients, such as cannabinoids and terpenes—is supported by pilot and peer-reviewed published studies. The peer-reviewed journal, Molecules, published the results of a double-blind, cross-over design study comparing the pharmacokinetic parameters of a broad-spectrum hemp extract formulated with VESIsorb to that of the same broad-spectrum hemp extract combined with medium chain triglyceride (MCT) oil. Overall, the VESIsorb formulation showed statistically significant improvements for all measured pharmacokinetic parameters.
“We are extremely proud to expand our relationship with Nestlé’s healthcare professional brands into Europe after their success in the U.S. market this past year,” said Jesse Lopez, CEO and founder of Geocann, in a press release. “Their leadership team’s validation of science-backed and clinically-proven hemp products is an important milestone for our industry and provides exceptional credibility to the therapeutic benefits of cannabinoids formulated with VESIsorb.”